http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0663905-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37555e87c88017b74fba94c8b8abbb42 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-06 |
| filingDate | 1993-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b854c462abbe4cac7c4025508ff0e8ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_300daf002670123e42f1e05c69404e84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d17e3a905f405806b7905e5ac51c8d1a |
| publicationDate | 1995-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0663905-A1 |
| titleOfInvention | NEW PROCESS FOR THE ESTERIFICATION OF BACCATIN III AND DESACETYL-10 BACCATIN III. |
| abstract | PCT No. PCT/FR93/00965 Sec. 371 Date Apr. 5, 1995 Sec. 102(e) Date Apr. 5, 1995 PCT Filed Oct. 4, 1993 PCT Pub. No. WO94/07876 PCT Pub. Date Apr. 14, 1994This invention relates to a method of preparing esters of baccatine III or 10-deacetylbaccatine III of formula (I) by esterification of protected baccatine III or 10-deacetylbaccatine III of formula (II) by means of an activated acid of formula (III). The esters of formula (I) can be used to prepare taxane derivatives having remarkable antileucemia and antitumor properties. In formulae (I), (II) and (III) Ar is an aryl radical, R1 is a hydrogen atom or an aryl radical or an R4-O-CO- radical (R4=alkenyl, alkynyl, optionally substituted alkyl, cycloalkyl, cycloalkynyl, bicycloalkyl, phenyl, heterocyclyle) and R2 is a hydrogen atom, and R3 stands for a hydroxy function protection grouping, or R1 is defined as above and R2 and R3 together form a 5 or 6 membered, saturated heterocyclic ring, G1 is an acetyl radical or a hydroxy function protection grouping, G2 is a hydroxy function protection grouping, and X is an acyl radical, aryl, radical or halogen atom. <IMAGE> (I) <IMAGE> (II) <IMAGE> (III) |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6911549-B1 |
| priorityDate | 1992-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.